Frazier Lifesciences Acquisition Corporation

NasdaqCM:FLAC Stock Report

Market Cap: US$183.7m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Frazier Lifesciences Acquisition Balance Sheet Health

Financial Health criteria checks 3/6

Key information

n/a

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$375.55k
Equity-US$11.67m
Total liabilitiesUS$150.95m
Total assetsUS$139.28m

Recent financial health updates

Recent updates

Frazier Lifesciences SPAC said in talks to take NewAmsterdam Pharma public

Jul 19

Financial Position Analysis

Short Term Liabilities: FLAC has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: FLAC has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: FLAC is debt free.

Reducing Debt: FLAC's has negative shareholder equity, so we do not need to check if its debt has reduced over time.

Debt Coverage: FLAC has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: FLAC has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies